[Form 4] Doximity, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Benjamin Regina M., a director of Doximity, Inc. (DOCS), reported transactions dated 08/08/2025. The Form 4 shows the conversion of 5,000 shares of Class B Common Stock into Class A Common Stock and the sale of 5,000 shares of Class A Common Stock at $63 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted February 26, 2025.

Following the reported transactions the form lists the Reporting Person's beneficial ownership as 16,618 shares of Class A Common Stock. The filing also discloses derivative/option positions, with one line showing 361,138 derivative-equivalent shares beneficially owned after the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/11/2025.

Positive

• Sale was executed under a Rule 10b5-1 trading plan adopted on 02/26/2025, indicating a preplanned transaction
• Conversion of Class B to Class A is documented and consistent with the issuer's conversion provisions

Negative

• Director sold 5,000 Class A shares at $63 per share on 08/08/2025, reducing direct Class A holdings to 16,618 shares

Insights

Financial Analyst

TL;DR: Director sold 5,000 DOCS shares at $63 under a pre-existing 10b5-1 plan; reported holdings declined accordingly.

The filing documents a routine insider transaction: conversion of 5,000 Class B shares to Class A and an automatic sale of 5,000 Class A shares at $63 executed pursuant to a Rule 10b5-1 plan adopted 02/26/2025. Reported direct Class A ownership after the transactions is 16,618 shares. The Form also reports significant derivative-equivalent holdings (the filing lists 361,138 shares in a derivatives row). From a capital-markets perspective, this is a disclosed, preplanned sale and is typically treated as non-surprising market activity; the filing provides clear quantities and execution price for modeling small changes in insider holdings.

Corporate Governance Expert

TL;DR: Transaction executed under an established 10b5-1 plan and conversions per charter; this is a standard, documented insider disclosure.

The Form 4 indicates the director used an established Rule 10b5-1 trading plan for the sale, which reduces concerns about opportunistic timing because the plan was adopted on 02/26/2025. The filing also documents conversion mechanics for Class B to Class A shares consistent with the issuer's charter. The signature by an attorney-in-fact on 08/11/2025 satisfies the procedural filing requirement. Overall, governance procedures appear followed and the disclosure is routine.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Benjamin Regina M.

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/08/2025		C(1)		5,000	A	(1)	21,618	D
Class A Common Stock	08/08/2025		S(2)		5,000	D	$63	16,618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.21	08/08/2025		M			5,000	(3)	09/01/2030	Class B Common Stock(4)	5,000	$0	361,138	D
Class B Common Stock	(4)	08/08/2025		M		5,000		(4)	(4)	Class A Common Stock	5,000	$0	5,000	D
Class B Common Stock	(4)	08/08/2025		C(1)			5,000	(4)	(4)	Class A Common Stock	5,000	$0	0	D

Explanation of Responses:

1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025.

3. The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 2, 2020.

4. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

Remarks:

	/s/ Jennifer Chaloemtiarana, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Doximity (DOCS)?

The Form 4 was filed on behalf of Benjamin Regina M., identified in the filing as a Director of Doximity.

What transactions are reported on this DOCS Form 4 dated 08/08/2025?

The filing reports conversion of 5,000 Class B shares into Class A and an automatic sale of 5,000 Class A shares at $63 per share on 08/08/2025.

Was the sale executed under a trading plan for DOCS insider?

Yes. The sales were reported to occur automatically pursuant to a Rule 10b5-1 trading plan adopted on 02/26/2025.

What beneficial ownership is reported after the transactions?

The Form reports 16,618 shares of Class A Common Stock beneficially owned after the transactions and a derivatives row listing 361,138 shares as derivative-equivalent holdings.

Who signed the Form 4 and when was it signed?

The Form 4 is signed by Jennifer Chaloemtiarana, Attorney-in-Fact on 08/11/2025.